Skip to main content

Table 2 Incidence and severity characteristics of sufentanil induced coughs

From: RETRACTED ARTICLE: Dose selection of central or peripheral administration of sufentanil affect opioid induced cough?: a prospective, randomized, controlled trial

 

Group CV (n = 51)

Group PV (n = 51)

P value

Occurrence of cough, n (%)

10 (20.4)

16 (32)

0.04*

 Mild

4 (7.84)

5 (9.80)

0.36

 Moderate

5 (9.80)

5 (9.80)

1.00

 Severe

1 (1.96)

6 (11.76)

0.03*

Onset time of cough (s)

18.3 ± 3.0

18.5 ± 2.8

0.93

  1. Group CVcentral venous group, Group PV peripheral venous group
  2. Values are mean ± SD or numbers (percentage). Chi-Square test was used. A p value of < 0.05 was considered statistically significant
  3. *p <0.05, group CV vs. group PV
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us